<aside> 🧭

Quick nav: Home · Products · Services · Applications · Publications · Technical Knowledge Base · Validated Antibody list · About · FAQ · Distributors & Partners · Procurement & Logistics · Contact · News

</aside>

What conventional workflow deliver

Read to understand what and how the conventional workflow create enormous challenges for researchers.

Read to understand what and how the conventional workflow create enormous challenges for researchers.

Whole Blood Do Data

Stop letting simple things destroy your immune data. Explore more what whole blood workflow can help you to land in accurate results and outcome.

In summary Today's two options were both broken.

Fresh blood Accurate — but you're locked to one site, one instrument, same-day turnaround. Try to scale it across a multi-site trial and the logistics collapse under their own weight

PBMC isolation. Decouples the draw from analysis — but at a real cost. Granulocytes are discarded entirely (half your innate immune system, gone). Monocyte viability drops 50–70% during the gradient spin. Isolation technique varies 2–3× between operators, and that variance survives every downstream statistical correction. The gradient process itself activates cells, so you can no longer tell true baseline activation from an isolation artifact.

The result: larger cohorts don't dilute the noise — they compound it. Longer studies, more variance sources, weaker conclusions.

THE COST, IN NUMBERS

• 50% of the innate immune response lost when granulocytes are discarded during PBMC isolation
• 50–70% monocyte viability loss during density-gradient separation
• 2–3× operator-to-operator variability in manual yields
• 2–3 hours of labor per batch spent on isolation alone
• $300–500 per express shipment for fresh or fragile samples — before your study even scales

The solution

We are presenting you the only end-to-end whole-blood system designed as one workflow, not separate products bolted together.